In SSc, the expression of iNOS in the endothelium, smooth muscle cells, fibroblasts, macrophages and many other cell types is robustly induced by inflammatory mediators and cytokines and its activity is increased at inflammatory sites (8). This evidence concerns the gene NOS2 and systemic sclerosis.